Futuximab

Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity[1].

Product Specifications

CAS Number

[1310460-85-5]

UNSPSC

12352203

Target

EGFR

Type

Inhibitory Antibodies

Related Pathways

JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/futuximab.html

Purity

98.09

Solubility

10 mM in DMSO

Smiles

[Futuximab]

Molecular Weight

(146.28 kDa)

References & Citations

[1]Stephen T Keir, et al. Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models. J Neurooncol. 2018 Jul;138 (3) :489-498.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MR210110L4V 200 µL

Mettl13 (NM_144877) Mouse Tagged ORF Clone Lentiviral Particle

Ask

View Details

YF-PA13366 50 ug

anti-NDUFA3

Ask

View Details

RC219608L4V 200 µL

INSC (NM_001031853) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

MBS9371887 Inquire

Plant Parathyroid Hormone Receptor 2 (PTHR2) ELISA Kit

Ask

View Details

CF505182 100 µg

FATE1 Mouse Monoclonal Antibody [Clone ID: OTI3D7]

Ask

View Details

abx979919-01 150 µg

Mouse COPS8 shRNA Plasmid

Ask

View Details